Clinical Trials Browser

Phase NA × OTHER × Advanced Malignant Solid Tumors × Clear all

NCT05749627 2025-02-27

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT03047811 2017-02-09

The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors

Phase NA Unknown

Other solid neoplasm

Advanced Malignant Solid Tumors